Jonah Shacknai - Net Worth and Insider Trading

Jonah Shacknai Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jonah Shacknai owns 2 companies in total, including Obalon Therapeutics Inc (OBLN) , and Reshape Lifesciences Inc (RSLS) .

Click here to see the complete history of Jonah Shacknai’s form 4 insider trades.

Insider Ownership Summary of Jonah Shacknai

Ticker Comapny Transaction Date Type of Owner
OBLN Obalon Therapeutics Inc 2018-06-13 director
RSLS Reshape Lifesciences Inc 2017-01-12 director

Jonah Shacknai Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Jonah Shacknai Ownership Network

Ownership Network List of Jonah Shacknai

No Data

Ownership Network Relation of Jonah Shacknai


Jonah Shacknai Owned Company Details

What does Obalon Therapeutics Inc do?

Who are the key executives at Obalon Therapeutics Inc?

Jonah Shacknai is the director of Obalon Therapeutics Inc. Other key executives at Obalon Therapeutics Inc include director & President & CEO & Exec Chairman Andrew P Rasdal , Chief Financial Officer Nooshin Hussainy , and Chief Technology Officer Mark Brister .

Obalon Therapeutics Inc (OBLN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Obalon Therapeutics Inc (OBLN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Obalon Therapeutics Inc (OBLN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Obalon Therapeutics Inc (OBLN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Obalon Therapeutics Inc Insider Transactions

No Available Data

Jonah Shacknai Mailing Address

Above is the net worth, insider trading, and ownership report for Jonah Shacknai. You might contact Jonah Shacknai via mailing address: 3333 E. Camelback Rd. Ste. 200, Phoenix Az 85018.

Discussions on Jonah Shacknai

No discussions yet.